34 results
424B3
BIAF
bioAffinity Technologies, Inc.
23 Sep 24
Prospectus supplement
4:00pm
of The Nasdaq Capital Market, such as the corporate governance requirements, the stockholder’s equity requirement, or the minimum closing bid price … and organizational skills to his position as Chairman of the Nominating and Governance Committee and to the Board.
Roby Joyce, MD — Director
Roby P
424B5
BIAF
bioAffinity Technologies, Inc.
5 Aug 24
Prospectus supplement for primary offering
9:00am
such as the corporate governance requirements, the stockholder’s equity requirement or the minimum closing bid price requirement, The Nasdaq Capital Market may take … satisfy certain corporate governance requirements. Our management and other personnel are required to devote a substantial amount of time to ensure
424B3
szb9itx
16 Apr 24
Prospectus supplement
7:19pm
POS AM
c02dg75 g8vfm
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
424B5
cgkef gyy8y8
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
klbwrwx3
7 Mar 24
Prospectus supplement for primary offering
9:57pm
424B5
e773fz
28 Nov 23
Prospectus supplement for primary offering
4:00pm
S-3
tt13lpnl ih
16 Nov 23
Shelf registration
5:23pm
8-K
EX-10.6
tb5ttk g1fgh4jup62
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-10.4
w4ncm
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-99.1
oab5xcos
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
DRS
t0e0b
14 Aug 23
Draft registration statement
12:00am